Chemokines, neuronal–glial interactions, and central processing of neuropathic pain
- 1 February 2010
- journal article
- review article
- Published by Elsevier BV in Pharmacology & Therapeutics
- Vol. 126 (1), 56-68
- https://doi.org/10.1016/j.pharmthera.2010.01.002
Abstract
No abstract availableThis publication has 158 references indexed in Scilit:
- Matrix metalloprotease regulation of neuropathic painTrends in Pharmacological Sciences, 2009
- MAP kinase and painBrain Research Reviews, 2009
- Chemokines and pain mechanismsBrain Research Reviews, 2009
- Dependence of monocyte chemoattractant protein 1 induced hyperalgesia on the isolectin B4-binding protein versicanNeuroscience, 2009
- Glia in pathological pain: A role for fractalkineJournal of Neuroimmunology, 2008
- CXCR4 chemokine receptor signaling mediates pain hypersensitivity in association with antiretroviral toxic neuropathyBrain, Behavior, and Immunity, 2007
- Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkineBrain, Behavior, and Immunity, 2007
- Alterations in immunological and neurological gene expression patterns in Alzheimer's disease tissuesExperimental Cell Research, 2007
- Possible role of spinal astrocytes in maintaining chronic pain sensitization: review of current evidence with focus on bFGF/JNK pathwayNeuron Glia Biology, 2006
- Expression of chemokines and their receptors in human and simian astrocytes: Evidence for a central role of TNFα and IFNγ in CXCR4 and CCR5 modulationGlia, 2003